Board of Directors
Coy F. BlevinsRobert W. Croce
William M. Facteau
Ross A. Jaffe, MD
Joshua Makower, MD
John M. Nehra
Hank A. Plain, Jr.
Christopher M. Smith
Thomas E. Timbie
Mr. Blevins has served as a member of the board of directors since April 2006. From January 1994 to March 2000, Mr. Blevins served as Vice President of Sales for Perclose. From January 1991 to January 1994, Mr. Blevins served as Area Sales Manager for Devices for Vascular Intervention. From February 1981 to December 1985, Mr. Blevins served as Director of Sales for three divisions of Baxter Healthcare. Mr. Blevins also serves on a number of private company boards. Mr. Blevins received his B.A. in Business Administration from Baylor University.
Mr. Croce has served as a member of the board of directors since April 2006. Mr. Croce is currently a Venture Partner of New Enterprise Associates, a venture capital firm. From January 1992 to December 2005, Mr. Croce served as Company Group Chairman at Ethicon Endo Surgery and Cordis, both Johnson & Johnson companies. From January 1990 to December 1992, Mr. Croce served as President at Ethicon, a Johnson & Johnson company. Mr. Croce also serves on a number of private company boards. Mr. Croce received his B.S. in Business Administration and M.B.A. from University of Central Missouri.
Mr. Facteau has served as the President and Chief Executive Officer and a member of our board of directors since November 2004. From November 1999 to November 2004, Mr. Facteau held a number of sales, marketing and general management positions at Abbott Vascular Devices. Mr. Facteau joined Abbott Laboratories via the acquisition of Perclose, a vessel closure company, where he was the Southeast Regional Sales Manager. From July 1993 to April 1998, Mr. Facteau worked in sales and sales management at United States Surgical Corporation. Mr. Facteau received his B.A. in Political Science from the University of Connecticut.
Dr. Jaffe has served as a member of the board of directors since January 2005. Dr. Jaffe is currently a Managing Director of Versant Ventures, a venture capital firm that he co-founded in 1999. Dr. Jaffe currently serves on the board of Insulet. Dr. Jaffe also serves on a number of private company boards. Dr. Jaffe received his B.A. in Policy Studies from Dartmouth College, his M.D. from Johns Hopkins University and his M.B.A. from Stanford University.
Dr. Makower is a co-founder of the Company and has served as Chairman of the board of directors since November 2004. Dr. Makower also served as our President and Chief Executive Officer from June 2004 to November 2004. Dr. Makower is currently Chief Executive Officer at ExploraMed II, a Venture Partner of New Enterprise Associates, a venture capital firm, a Consulting Associate Professor of Medicine at Stanford University Medical School and a Co-Founder of Stanford’s Biodesign Innovation Program. From February 1996 to October 2003, Dr. Makower held various founding and leadership roles at TransVascular, a medical device company focused on minimally-invasive catheter-based surgical systems. Dr. Makower also serves on a number of private company boards. Dr. Makower received his B.S. in Mechanical Engineering from the Massachusetts Institute of Technology, his M.B.A. from Columbia University and his M.D. from the New York University School of Medicine.
Mr. Nehra has served as a member of the board of directors since June 2004. Mr. Nehra has been a Special Partner of New Enterprise Associates, a venture capital firm, since October 2000 and was a General Partner of New Enterprise Associates from December1993 until October 2000. Mr. Nehra has served as a General Partner of Catalyst Ventures, a venture capital firm, since January 1989. Mr. Nehra currently serves on the board of directors and compensation committee of Davita. Mr. Nehra has also served on the board for the Baltimore School for the Arts since 1997and recently joined the board of The Johns Hopkins University Carey Business School in May 2008, he also sits on a number of private company boards. Mr. Nehra received his B.A. in Economics from the University of Michigan.
Mr. Plain has served as a member of the board of directors since December 2004. Mr. Plain is a Partner with Morgenthaler Ventures, a venture capital firm, Vice Chairman of The Foundry, a medical device incubator and Chairman of the board of Xtent. From June 2000 to March 2001, Mr. Plain served as Chairman of the Board of Embolic Protection, which was acquired by Boston Scientific. From February 1993 to November 1999, Mr. Plain was the President and Chief Executive Officer and a member of the board of directors of Perclose. During this time, Mr. Plain directed Perclose through an initial public offering, a secondary offering, and an acquisition by Abbott Laboratories in November 1999. Following the acquisition of Perclose by Abbott Laboratories, Mr. Plain served as the President of Perclose and Vice President of Hospital Products Division at Abbott Laboratories until May 2000. Mr. Plain also serves on a number of private company boards. Mr. Plain received his B.S. in Finance from the University of Missouri, Columbia.
Mr. Smith has served as a member of the board of directors since November 2004. Mr. Smith is currently President of Cochlear Americas, a developer of an implantable hearing device. From October 2003 to August 2004, Mr. Smith served as a Consultant for Warburg Pincus, an investment bank. From August 2000 to October 2003, Mr. Smith served as Group President for Gyrus Group, President and President and CEO-Director of Gyrus Medical. Mr. Smith also serves on a number of private company boards. Mr. Smith received his B.S. in Journalism and Marketing from Texas A&M University.
Mr. Timbie has served as a member of the board of directors since April 2007. Mr. Timbie is currently the President of Timbie & Company, a financial consulting firm that he founded in 2000. From January 2005 to June 2005, Mr. Timbie served as Interim Vice President and Chief Financial Officer for ev3, an endovascular company. From April 1996 to December 1999, Mr. Timbie served as Vice President and Chief Financial Officer of Xomed, an ENT company. Mr. Timbie currently serves on the board of American Medical Systems Holdings, Wright Medical Group and ev3. Mr. Timbie received his B.S. in Accounting from the University of Florida and his M.B.A. from Stetson University.